Semaglutide is highly effective for obesity management, achieving mean weight losses of 1517% in clinical trials
Rovamo LM, Salmenpera L, Arjomaa P, et al
While its efficacy and safety profile are comparable to oral Wegovy , it falls significantly short of Eli Lillys subcutaneous tirzepatide the gold standard of GLP-1 analogs to date (technically a dual agonist mimicking both GLP-1 and GIP)
The most commonly reported side effects for both agents are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
Results RNA formulas are clean GMO-free, gluten-free, dairy-free, carrier-free and vegan-friendly
Always ask for a recent third-party HPLC COA before buying, and skip any seller that hides its lab data